Tuesday Sessions – Day Three – October 20
Renowned experts in thyroid function and biology, diagnosis and management of thyroid disease, and novel therapies for treating thyroid cancer will gather at the 15th International Thyroid Congress (ITC) to present, discuss, and debate the latest advances in thyroidology. The ITC will take place October 18-23, 2015 at the Walt Disney World Swan and Dolphin Resort in Lake Buena Vista, Florida. Held every five years, the ITC is a collaborative meeting of the four world thyroid associations held every fifth year: ATA (American Thyroid Association), Asia-Oceania Thyroid Association (AOTA), European Thyroid Association (ETA), and Latin American Thyroid Society (LATS).
Two special lectures highlight the third day of programming at ITC, on Tuesday, October 20. In the morning, Luigi Bartalena will deliver the Plenary Lecture entitled “Choice of Therapy for Graves’ Hyperthyroidism,” with an introduction by Furio Pacini. Delivering the AOTA Prize Lecture, “Toward Best Management of Thyroid Cancer” in the afternoon will be Akira Miyauchi, introduced by Takashi Akamizu.
The Women in Thyroidology Networking Meeting, with the theme “The Mentor Within” and led by Ofelia Olivero will take place Tuesday afternoon.
The ITC Program Committee has scheduled a series of provocative Discussions/Debates on Tuesday, Day Three of the Congress, one focusing on clinical topics and the other areas related to basic and translational research. The Clinical Discussions/Debates will explore a range of controversial topics: “How Reliable are Free Thyroid Hormone Assays?” with Stefan K.G. Grebe and Steve Soldin; “Rituximab Therapy for Graves’ Orbitopathy” with Mario Salvi and Marius N. Stan; “Maternal Isolated Hypothyroxinemia: What Do We Know and What Don’t We Know?” with Marco Medici and Chrysoula Dosiou; “Is it Possible to Improve Outcomes in Congenital Hypothyroidism?” with Stephen H. LaFranchi and Tone Torresani; “Emerging Concepts In The Management of Recurrent Thyroid Cancer” with Kenneth Burman and Enrico Papini.
Tuesday’s Basic/Translational Discussions/Debates will feature the following topics and participants: “Clinical and Basic Aspects of Bone Turnover by Thyroid Hormone” with John G. Logan and Bente Langdahl; “Roles of TSH from Pars Tuberalis and Pars Distalis” with Takashi Yoshimura; “Thyroid Function and Metabolic Syndrome” with Gabriela Brenta and Jiajun Zhao; “Deiodinases and Cancer” with Stephen A. Huang and Domenico Salvatore; and “TSHR Structure” with Jane Sanders and Ricardo Núñez Miguel.
Symposiums on an array of timely topics chaired by international experts and featuring leading researchers and clinicians invited to share their knowledge and experiences will take place throughout the day on Tuesday. Beginning with the Early Riser Symposium, Chairs Rossana Corbo and Andrew J. Bauer have organized a session entitled ” Differences Between Pediatric and Adult Differentiated Thyroid Cancer” featuring Sylvia L. Asa speaking on Thyroid Cancer Phenotypes; Cristoph Reiners on Approach to Radioiodine Treatment; Fernanda Vaisman on Thyroid Cancer Outcome; and Steven G. Waguespack on ” Thyroid Cancer Guidelines.”
Tuesday morning’s program continues with four parallel Oral Abstracts sessions. Two sessions will focus on Clinical topics, including “Thyroid Cancer Therapy and Outcomes” led by Chairs Duncan Topliss and Sara Ahmadi, and “Autoimmunity and Pregnancy” with Chairs Yasumasa Iwasaki and Maria Cabanillas. The Basic Oral Abstract sessions are entitled “Thyroid Signaling Metabolism and Action,” led by Chairs Sheue-yann Cheng and Juan Nicola, and “Thyroid Cancer Genetics/Genomics, with Chairs Rafaelle Ciampi and Rebecca Schweppe.
ITC’s Tuesday afternoon program will feature a set of four symposia on various highly relevant topics beginning with the “Clark T. Sawin Historical Vignettes” led by Moderator Leonard Wartofsky, in which Lewis E. Braverman will speak on the History of the ITC; Shigenobu Nagataki will discuss the History of AOTA; Eduardo Pretell will present LATS and Regional Thyroid Highlights; and Wilmar Wiersinga will share his Thoughts about the History of the ETA.
Exploring ”TH Metabolism –Translational Physiology” will be session Chairs Anne van der Spek and Salvatore Benvenga, with a talk on Genetic and Functional Variation in Type 2 Deiodinase to be presented by Elizabeth A. McAninch; a presentation on Animal Models of Non-Thyroidal Illness by Emmely de Vries; and a discussion of “Metabolism in Human NTI” by Greet van den Berghe.
The Tuesday afternoon symposia at ITC will also include a session entitled “Fetal Programming in Maternal Thyroid Disease.” Joining Daniel Glinoer and Joanne Rovet are presenters Juan Bernal discussing Thyroid Hormone and Brain Development; Georg Brabant speaking on Brain Morphological Changes in Children Born to Mothers with Hypothyroidism; and Stine Linding Andersen focusing on Neurodevelopmental Disorders in Children Born to Mothers with Thyroid Dysfunction.
The symposium “Emerging Genes and Pathways in Thyroid Cancer” led by Chairs Sissy Jhiang and Keith Bible will include presentations on Molecular Genetics of Thyroid Tumor Progression by Paula Soares; Genetics of Radiation-Associated Thyroid Cancer by Horst Zitzelsberger; and Molecular Determinants of Signaling and Differentiation in Thyroid Cancer by Pilar Santisteban.
The ITC Program Organizing Committee (POC) has invited renowned international thyroid experts for every symposium and discussion/debate. The POC has designed this ITC to highlight and involve young investigators from around the world. The American Thyroid Association (ATA) will continue to promote the E. Chester Ridgway Trainee Conference with a unique and focused track for trainees; participation includes accommodations and complimentary registration for a limited number of applicants who are first authors on accepted abstracts. The four international thyroid associations combine their efforts to contribute to this one of a kind, state-of-the-science experience! Don’t miss this “top of the mark” collegial event.
Hosted by the ATA, the ITC will bring together the international community of thyroid researchers and clinicians to present and discuss the latest advances and controversies in thyroidology. The ATA and its annual meetings are well known and well regarded by all those devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health.
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,700 members from 43 countries around the world. Celebrating its 92nd anniversary, the ATA delivers its mission — of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website serves as the clinical resource for patients and the public who look for reliable information on the Internet. Every fifth year, the American Thyroid Association joins with the Latin American Thyroid Society, the European Thyroid Association, and the Asia and Oceania Thyroid Association to co-sponsor the International Thyroid Congress (ITC). This year the ITC is hosted by the American Thyroid Association at the Walt Disney World Swan and Dolphin Resort. More information about the 15th ITC can be found at http://www.thyroid.org/itc2015/.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.